American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

By M. Hammond, Daniel F. Hayes, Mitchell Dowsett, D. Allred, K. Hagerty, S. Badve, P. Fitzgibbons, G. Francis, Neil S. Goldstein, M. Hayes and 22 more. Journal of Clinical Oncology, 2010

1,006 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Oncology

View Paper: https://www.semanticscholar.org/paper/e0e5f5e84698e1dd7d8ab25765952535ffd9c658

Citations in the corpus

• Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study (2019, neutral): “Men and women were eligible for enrollment if they were aged 18 years, had centrally confirmed TNBC [10], an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, baseline lactate dehydrogenase (LDH) levels <2.”